
| Salt Composition: | Cefuroxime (500mg) + Clavulanic Acid (125mg) |
| Manufacturer: | Pharma Drugs & Chemicals |
| Storage: | Below 25 degree celcius |
Out of Stock
Have doubts about this medicine?
Have doubts about this medicine?
Cefresh-CV 500mg/125mg Tablet is a combination medicine used to treat various types of bacterial infections by preventing the growth and spread of microorganisms. Cefresh-CV 500mg/125mg Tablet is a prescription medicine used to treat bacterial infections. It can be taken with or without food but should be taken at a fixed time for better efficacy. Do not exceed the recommended dose, and complete the full course of treatment even if you feel better. Common side effects include nausea, vomiting, diarrhea, and indigestion. Seek immediate medical help if you experience any allergic reactions. Pregnant or breastfeeding women should consult their doctor before taking this medicine. Avoid alcohol as it can cause excessive drowsiness. Adequate rest, a healthy diet, and plenty of water are recommended for faster recovery.
Cefresh-CV 500mg/125mg Tablet is a combination of Cefuroxime and Clavulanic Acid. Cefuroxime prevents the formation of the bacterial protective covering, essential for bacterial survival. Clavulanic Acid blocks enzymes produced by bacteria to inactivate Cefuroxime, reducing resistance and enhancing its activity against bacteria.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush, or break it. Cefresh-CV 500mg/125mg Tablet may be taken with or without food, but it is better to take it at a fixed time.
Alcohol
Consuming alcohol with Cefresh-CV 500mg/125mg Tablet does not cause any harmful side effects.
Breastfeed
Cefresh-CV 500mg/125mg Tablet is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
Pregnancy
Cefresh-CV 500mg/125mg Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.